No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
QNRX Quoin Pharmaceuticals
- 0.6862
- -0.0338-4.69%
Close Jun 14 16:00 ET
2.73MMarket Cap-103P/E (TTM)
0.7382High0.6816Low44.43KVolume0.7201Open0.7200Pre Close30.95KTurnover1.12%Turnover RatioLossP/E (Static)3.98MShares12.000052wk High0.30P/B2.72MFloat Cap0.602952wk Low--Dividend TTM3.96MShs Float40500.0000Historical High--Div YieldTTM7.87%Amplitude0.6029Historical Low0.6960Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Maxim Group Maintains Quoin Pharmaceuticals(QNRX.US) With Buy Rating, Maintains Target Price $4
Maxim Group analyst Naz Rahman maintains $Quoin Pharmaceuticals(QNRX.US)$ with a buy rating, and maintains the target price at $4.According to TipRanks data, the analyst has a success rate of 27.6% an
Express News | Quoin Pharmaceuticals Signs Research Agreement With University College Cork Encompassing The Development Of Topical Formulations Of Rapamycin
Quoin Pharmaceuticals Announces Signing of Research Agreement With University College Cork (UCC), Ireland
Agreement will focus on the development of novel topical rapamycin (sirolimus) formulations as potential treatments for a number of rare and orphan diseasesUCC's proprietary dissolvable microneedles t
Quoin Pharmaceuticals(QNRX.US) Director Sells US$217.4 in Common Stock
$Quoin Pharmaceuticals(QNRX.US)$ Director LANGER DENNIS sold 297 shares of common stock on Jun 7, 2024 at an average price of $0.732 for a total value of $217.4.Source: Announcement What is statement
Quoin Pharmaceuticals on the Brink: Nasdaq Deficiency Notice Threatens Stability and Investor Confidence
Analysts Offer Insights on Healthcare Companies: Zevra Therapeutics (ZVRA), ALX Oncology Holdings (ALXO) and Quoin Pharmaceuticals (QNRX)
Comments
$Quoin Pharmaceuticals(QNRX.US$ Quoin Pharmaceuticals Signs Research Agreement With University College Cork Encompassing The Development Of Topical Formulations Of Rapamycin
$Quoin Pharmaceuticals(QNRX.US$
ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best efforts" public offering of 4,062,500 ordinary shares represented by 4,062,500 American Depositary Shares (or pre-funded warrants in lieu thereof), Series D warrants to purchase an aggregate of up to 4,06...
ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best efforts" public offering of 4,062,500 ordinary shares represented by 4,062,500 American Depositary Shares (or pre-funded warrants in lieu thereof), Series D warrants to purchase an aggregate of up to 4,06...
2
$Quoin Pharmaceuticals(QNRX.US$
let's hope that's the catalyst needed to get this back over 4
let's hope that's the catalyst needed to get this back over 4
1
$Quoin Pharmaceuticals(QNRX.US$ looks to be consolidating. I see blocks in the 1.30 range. That's likely where it'll go before it takes off. Then 🚀 to the 🌙!
1
3
will need to take a trip to the 
. Hope your 
are packed. The 14th will come fast.Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg